Human PD-L1 inhibitor II - 1 mg
- Cat.Number : AS-65582
- Manufacturer Ref. :
-
Availability :
In stock
Alternative choices
Programed cell death 1 (PD-1) receptor and its ligand PD-L1 are crucial immune checkpoints to downregulate T cell activation, tolerance and immunopathology. Several types of cancer cells were identified to overexpress PD-L1 so as to escape from the PD-1/PD-L1 immunosurveillance mechanism. This peptide, hPDL-1 inhibitor II binds to human PD-1 and inhibits PD-1/PD-L1 binding. It has anchor residues, WDY that show a great impact on the binding of hPD-L1 to hPD-1. Developing molecules specifically blocking the PD-1/PD-L1 pathway has become popular approach to cancer treatment.
Specifications
Chemistry | |
Sequence one letter code |
|
---|---|
Sequence three letter code |
|
Molecular Formula |
|
Molecular Mass/ Weight |
|
Modification | |
Conjugation |
|
Quantity & Purity | |
Purity |
|
Storage & stability | |
Form |
|
Storage Conditions |
|
Activity | |
Biomarker Target | |
Research Area | |
Sub-category Research Area | |
Usage |
|
Source | |
Source / Species |
|
Codes | |
Code Nacres |
|
Downloads
You may also be interested in the following product(s)
![Image of a kit SensoLyte Rh110 Matriptase Activity Assay Kit Fluorimetric](/assets/cache/a73e7835-d2b3-4faf-af03-ba9116aa2011/500x500/as-72241-img-en-as-72241-01.jpg)
SensoLyte® Rh110 Matriptase Activity Assay Kit Fluorimetric - 1 kit
![Tube of Thrombospondin inhibitor peptide](/assets/cache/a7a0b397-7a22-4e15-9d4a-25b251cc1ab9/500x500/as-60877-img-en-as-60877-01.jpg)